terican

Last verified · v1.0

Calculator · health

Creatinine Clearance (Cr Cl) Calculator

Calculate creatinine clearance (CrCl) with the Cockcroft-Gault equation using age, sex, weight, and serum creatinine for accurate renal drug dosing.

FreeInstantNo signupOpen source

Inputs

Creatinine Clearance

—

Explain my result

0/3 free

Get a plain-English breakdown of your result with practical next steps.

Creatinine Clearance—mL/min

The formula

How the
result is
computed.

What Is Creatinine Clearance?

Creatinine clearance (CrCl) measures the rate at which the kidneys filter creatinine — a waste product of muscle metabolism — from the blood. Expressed in milliliters per minute (mL/min), CrCl serves as a practical surrogate for glomerular filtration rate (GFR) and is the gold-standard metric for renal-based drug dosing in clinical pharmacy and medicine.

The Cockcroft-Gault Equation

This CrCl calculator applies the Cockcroft-Gault equation, first published by Donald Cockcroft and Henry Gault in Nephron (1976). The formula is:

CrCl (mL/min) = [(140 − age) × weight × sex factor] ÷ (72 × serum creatinine)

  • Age: Patient age in years
  • Weight: Body weight in kilograms — actual body weight for most patients; adjusted body weight recommended for obese patients (BMI ≥30 kg/m²)
  • Sex factor: 1.0 for males; 0.85 for females
  • Serum creatinine (SCr): Measured in mg/dL from a standard metabolic panel

Why the Constant 72?

The denominator constant 72 normalizes the equation output to mL/min. It was derived empirically from the original study cohort and has been validated across subsequent large-scale clinical analyses, including pharmacokinetic studies of renally cleared antibiotics and anticoagulants.

Why 0.85 for Females?

Women typically carry approximately 15% less skeletal muscle mass than men of equivalent age and weight, producing less creatinine at baseline. The 0.85 sex-correction factor prevents systematic overestimation of renal clearance in female patients, improving dosing accuracy for renally eliminated drugs.

Understanding Each Variable

Age

Renal function naturally declines with age. The term (140 − age) directly encodes this relationship: a 30-year-old contributes a value of 110 to the numerator, while a 75-year-old contributes only 65. This reflects the well-documented progressive reduction in GFR averaging 0.75–1 mL/min per year after age 40.

Weight

Actual body weight (ABW) is standard for non-obese patients. For those with BMI ≥30 kg/m², most clinical guidelines recommend adjusted body weight (AdjBW = IBW + 0.4 × [ABW − IBW]) to prevent overestimation of CrCl, which could produce toxic drug exposures. Ideal body weight (IBW) alone may be appropriate for certain drug protocols — always consult drug-specific package labeling.

Serum Creatinine (SCr)

A low SCr does not universally indicate good kidney function. In elderly, malnourished, or muscle-wasting patients, creatinine production is reduced, keeping SCr artificially low and potentially inflating calculated CrCl. Clinicians should interpret results within the full clinical context, including muscle mass, nutritional status, and trending SCr values over time.

Normal CrCl Reference Ranges

  • Normal — Male: 97–137 mL/min
  • Normal — Female: 88–128 mL/min
  • CKD Stage 2 (mild): 60–89 mL/min
  • CKD Stage 3 (moderate): 30–59 mL/min
  • CKD Stage 4 (severe): 15–29 mL/min
  • CKD Stage 5 / Kidney Failure: <15 mL/min

Worked Clinical Example

A 68-year-old female patient weighs 65 kg and has a serum creatinine of 1.2 mg/dL.

CrCl = [(140 − 68) × 65 × 0.85] ÷ (72 × 1.2) = [72 × 65 × 0.85] ÷ 86.4 = 3,978 ÷ 86.4 ≈ 46.0 mL/min

This result places the patient in CKD Stage 3b — moderate-to-severe renal impairment — flagging the need for dose reduction in many renally cleared medications, including direct oral anticoagulants and antivirals used in hepatitis B and C treatment.

Clinical Applications

Regulatory agencies and drug package inserts specify dosing thresholds in CrCl from the Cockcroft-Gault equation for a wide range of drug classes: anticoagulants (apixaban, rivaroxaban, dabigatran), antibiotics (vancomycin, aminoglycosides), antivirals in HIV, hepatitis B, and hepatitis C treatment (tenofovir disoproxil fumarate, entecavir, ledipasvir/sofosbuvir), metformin, gabapentin, and renally cleared chemotherapy agents. Using eGFR from MDRD or CKD-EPI in place of Cockcroft-Gault CrCl can introduce clinically significant dosing errors because those equations are body-surface-area normalized and derived for CKD classification, not drug dosing.

Sources and Methodology

This calculator implements the Cockcroft-Gault equation as validated and applied in practice by the University of Washington National HIV Curriculum CrCl Calculator and the UW Hepatitis C Online CrCl Calculator. Additional methodological context is drawn from the PMC analysis on estimating creatinine clearance in the nonsteady state and the UIC College of Pharmacy GFR estimation and drug dosing guidance. Results are intended for educational and clinical decision-support purposes only and do not replace the judgment of a licensed healthcare provider.

Reference

Frequently asked questions

What is creatinine clearance (CrCl) and why is it clinically important?
Creatinine clearance estimates the volume of blood the kidneys filter per minute, using creatinine — a muscle metabolism byproduct — as the filtration marker. It serves as a GFR surrogate and is the primary metric referenced in drug dosing guidelines for renally eliminated medications. A CrCl below 60 mL/min typically triggers dose reductions, and a CrCl below 30 mL/min may contraindicate certain drugs entirely, making accurate calculation essential for patient safety.
What is the Cockcroft-Gault equation and how was it derived?
The Cockcroft-Gault equation — CrCl = [(140 − age) × weight × sex factor] ÷ (72 × SCr) — was developed in 1976 by Donald Cockcroft and Henry Gault from a study of 249 hospitalized male patients. The equation estimates renal clearance from age, body weight, sex, and serum creatinine without requiring a timed 24-hour urine collection, making it fast and practical for routine clinical and pharmacy use. It remains the standard equation cited in FDA drug labeling for renal dose adjustments.
What are normal creatinine clearance values for adults?
Normal CrCl for adult males ranges from 97 to 137 mL/min; for adult females, 88 to 128 mL/min. Values between 60–89 mL/min indicate mild kidney impairment (CKD Stage 2), 30–59 mL/min indicates moderate impairment (Stage 3), 15–29 mL/min indicates severe impairment (Stage 4), and values below 15 mL/min indicate kidney failure (Stage 5). Renal function declines an average of 0.75–1 mL/min per year after age 40, so lower values are expected in older adults even without overt kidney disease.
Should actual body weight or ideal body weight be used in the CrCl calculator?
For patients with a body mass index below 30 kg/m², actual body weight is the standard input. In obese patients (BMI ≥30), actual body weight overestimates CrCl because adipose tissue does not proportionally increase creatinine production. Most pharmacokinetic guidelines recommend adjusted body weight (IBW + 0.4 × [ABW − IBW]) for obese patients to prevent toxic drug exposures. Some drug-specific protocols specify ideal body weight alone — always consult the relevant package insert or institutional guideline for the correct weight descriptor.
How does CrCl from Cockcroft-Gault differ from eGFR calculated by CKD-EPI or MDRD?
Cockcroft-Gault CrCl and CKD-EPI/MDRD eGFR both estimate kidney function but differ in derivation, normalization, and intended clinical application. Cockcroft-Gault CrCl is not normalized to body surface area and is the value specified in nearly all FDA drug labeling for renal dose adjustments. CKD-EPI and MDRD eGFR are normalized to 1.73 m² BSA and are designed for CKD staging and epidemiology. Substituting eGFR for CrCl when determining medication doses can produce clinically significant over- or under-dosing errors, particularly in patients with extremes of body size or muscle mass.
Which medications require dose adjustment based on CrCl?
A wide range of commonly prescribed medications require CrCl-based dose adjustments. Key examples include direct oral anticoagulants (apixaban reduced or avoided below CrCl 25–30 mL/min; dabigatran contraindicated below 30 mL/min), vancomycin and aminoglycoside antibiotics (interval extended with declining CrCl), antivirals for HIV and hepatitis B/C treatment (tenofovir DF dose-adjusted below CrCl 50 mL/min), metformin (contraindicated below CrCl 30 mL/min), and gabapentin. Each drug's package insert specifies the exact CrCl thresholds triggering dose reduction, extended intervals, or contraindication.